News & Updates

Among patients with neovascular age-related macular degeneration (nAMD), fluctuations in retinal fluid volume during the maintenance phase antivascular endothelial growth factor (anti-VEGF) therapy may lead to long-term deterioration in visual acuity (VA), a recent study has found.

Intravitreal bevacizumab (IVB) injections induce short-lived visual benefit but ease the need for vitrectomy in proliferative diabetic retinopathy (PDR) patients with vitreous haemorrhage (VH) who had undergone prior complete panretinal photocoagulation (PRP), a recent study has found.

Differential diagnosis of preseptal and orbital cellulitis show “extremely sensitive” clinical presentation and C-reactive protein (CRP), according to a study, noting that prompt initiation of intravenous antibiotics is required and helps prevent surgical procedures even in those with incipient abscesses.

An ocular implant that continuously dispenses an antivascular endothelial growth factor (anti-VEGF) therapy into the vitreous performs well in the management of neovascular age-related macular degeneration, affording disease control and achieving vision and anatomical outcomes similar to that obtained with monthly intravitreal injections, as shown in the phase III ARCHWAY trial.

Certain systemic diseases, such as Sjögren syndrome (SS), facial rosacea, rheumatoid arthritis (RA), and peripheral artery disease, and a history of daily cigarette smoking are significantly associated with more severe dry eye disease (DED) signs, a study has found.

Patients with systemic lupus erythematosus (SLE) show progressive reduction in the thickness of peripapillary retinal nerve fibre layer, suggestive of early neurodegeneration, a recent study has found.